[KOREA PHARM on-site] Dongkwang Pharm Natural ingredient degenerative arthritis medicine ‘Aragan Plus Injection’

Dongkwang Pharm (CEO YByeong-gil Yu, www.dkpco.co.kr) participated in 2nd International Pharmaceutical Products Exhibition in 2012 (KOREA PHARM 2012) from May 22(Tue) to 25(Fri) in Kintex,  KOREA  showed ‘Aragan Plus Injection’ which is a natural ingredient degenerative arthritis medicine.

Aragan Plus Injection is a medical equipment which generates cartilage between bones without surgeries for senile degenerative arthritis patients. Existing ‘Aragan’ has to be injected 5 times consecutively for a week for one year treatment effects, but new ‘Aragan Plus’ can have the same effects by 3 times consecutive injection for a week by using polymer HA medicines.

Because polymer HA medicine has similar molecular weight with that of human body joint synovia, it warps the cartilages and makes cartilage movements smooth. This effect reduces patient’s pains and prevents joint cartilage degeneration. Additionally it has very little side effects because its uses natural ingredients.

Sales of this product in 2011 were 12 billion Korean won (based on domestic sales) and it is also being exported. In addition, it will be exported to Europe after CE certification this June.

Meanwhile, KOREA PACK 2012 (International Packaging Exhibition), KOREA MAT (Materials Handling & Logistics Exhibition), COPHEX 2012 (Cosmetic & Pharmaceutical Industry), KOREA PHARM 2012 (Pharmaceutical Ingredient Exhibition), KOREA CHEM 2012 (Chemical Plant Equipment & Processing), KOREA LAB 2012 (Laboratory & Analytical Equipment), and KOBEX 2012 (Bio & Environmental Equipment) will take place together, so people can meet varied industry fields at one spot.

In particular, KOREA PACK is selceted as a repreentative exhibiton of Gyeonggi-do, so they will be supported by Government and will be promoted as an International exhibition. Aso they will contribute to region economic development and cemployment creation by drawing lots of packaging related attention to Gyeonggi-do.

Go to ‘KOREA PHARM 2012′ Special Page

FacebookGoogle GmailPrintStumbleUponLinkedInShare

Speak Your Mind